Clinical trial
Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes
NCT00191178 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191178 |
|---|---|
| Title | Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes |
| Official title | Pilot Study Investigating the Effects of Insulin Lispro Low Mixture Therapy Compared With Insulin Glargine on Perceived Mood Symptoms in Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | insulin lispro protamine suspension:insulin lispro rDNA origin low mix, insulin glargine |
| Enrollment | 60 |
| Start date | Aug 1, 2003 |
| Completion | Jul 1, 2005 |
| First posted | Sep 19, 2005 |
| Last update posted | Oct 13, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: